Velcade (Bortezomib) Injection
4,656 / Box
Bortezomib is a type of targeted cancer drug. It is also known as Velcade. It is a treatment for myeloma and mantle cell lymphoma. You pronounce bortezomib as bor-teh-zoh-mib.
Initial data from ongoing trials in front line therapy are encouraging with response rates of 80%–90% when bortezomib is given in combination with other agents and importantly, the ability to mobilize peripheral blood stem cells is not impaired.
...more